News Oxford BioMedica could get $100m following CAR-T approval UK biotech will supply key component of Novartis' newly approved cancer cell therapy
News Novartis and FDA hail 'historic' Kymriah, first ever approve... In the end, the FDA took little more than six weeks to give final approval to Kymriah, the first ever CAR-T treatment.
Events Partner Content CRISPR & Precision Gene Editing Congress - Berlin 2017 CRISPR & Precision Gene Editing Congress Berlin 2017
News Show ambition with UK life sciences plan, Novartis tells gov... Drugmaker concerned over access to new drugs
Views & Analysis Novartis move shows chief digital officers can be prime chan... GSK and Novartis have just hired execs from the world of retail to be their chief digital officers - with the hope that they can lead transformation in R&D, and relationships with customers
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
